Geneos Wealth Management Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$15,000
-28.6%
1,7900.0%0.00%0.0%
Q1 2022$21,000
-16.0%
1,790
-13.1%
0.00%0.0%
Q4 2021$25,000
-46.8%
2,060
-33.4%
0.00%
-50.0%
Q3 2021$47,000
-6.0%
3,095
-11.4%
0.00%0.0%
Q2 2021$50,000
-13.8%
3,495
-23.1%
0.00%0.0%
Q1 2021$58,000
-28.4%
4,542
-10.8%
0.00%
-33.3%
Q4 2020$81,000
+55.8%
5,094
+25.9%
0.00%0.0%
Q3 2020$52,000
-23.5%
4,0470.0%0.00%
-25.0%
Q2 2020$68,000
+28.3%
4,047
-5.3%
0.00%0.0%
Q1 2020$53,000
-24.3%
4,2720.0%0.00%0.0%
Q4 2019$70,000
-10.3%
4,272
+1.2%
0.00%
-20.0%
Q3 2019$78,000
-18.8%
4,222
-6.1%
0.01%
-16.7%
Q2 2019$96,000
+9.1%
4,4970.0%0.01%0.0%
Q1 2019$88,000
+54.4%
4,4970.0%0.01%
+50.0%
Q4 2018$57,000
-59.3%
4,497
-23.1%
0.00%
-55.6%
Q3 2018$140,000
+48.9%
5,846
+18.8%
0.01%
+28.6%
Q2 2018$94,000
+56.7%
4,9210.0%0.01%
+40.0%
Q1 2018$60,000
-36.8%
4,921
-36.7%
0.01%
-37.5%
Q4 2017$95,000
+17.3%
7,772
+31.2%
0.01%0.0%
Q3 2017$81,000
-11.0%
5,922
-0.3%
0.01%
-11.1%
Q2 2017$91,000
+5.8%
5,941
+27.0%
0.01%0.0%
Q1 2017$86,000
+258.3%
4,679
+73.9%
0.01%
+200.0%
Q4 2016$24,000
+166.7%
2,690
+141.3%
0.00%
+200.0%
Q3 2016$9,0001,1150.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders